Topical Tofacitinib for Patients with Lichen Planopilaris and/or Frontal Fibrosing Alopecia

    Li-Chi Chen, Chino Ogbutor, Kristen J. Kelley, Maryanne M. Senna
    Studysummary This source discusses that while oral JAK inhibitors are used for treating lichen planopilaris and frontal fibrosing alopecia, they carry significant risk of adverse events; two cases showed promising results using tofacitinib cream as a safer topical alternative.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jaad.org →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Tofacitinib for the Treatment of Lichen Planopilaris: A Case Series Dermatologic therapy · 2018

    Related research 2

    1. Erosive Pustular Dermatosis of the Scalp: Causes and Treatments International Journal of Dermatology · 2020
    2. Off-Label Use of Topical Minoxidil in Alopecia: A Review American Journal of Clinical Dermatology · 2019